Tyra Biosciences

Tyra Biosciences

TYRA· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock +89.1% in FY2025

Todd Harris, Ph.D. is the CEO of Tyra Biosciences and was paid $5.6M in FY2025 (Dec), down 26%.

Pay$100 in the stock at the end of FY21 → $187
CEO pay is from each Tyra Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives3

See all
  1. 1Todd Harris, Ph.D.FY2025
  2. 2Bhavesh AsharFY2025
  3. 3Douglas Warner, M.D.FY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Tyra Biosciences paid its 3 named executives $12.6M in total in FY2025 (Dec). CEO Todd Harris, Ph.D. was paid $5.6M of that.

Name
Todd Harris, Ph.D.Chief Executive Officer
Bhavesh AsharChief Operating OfficerNot disclosedNot disclosed
Douglas Warner, M.D.Chief Medical OfficerNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for Tyra Biosciences. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Board2

See all
  • Robert MoreChair · 7 yr on the boardIndependentAudit, Nominating and Corporate Governance (Chair)—Paid as an executive
  • Rehan VerjeeDirector · 4 yr on the boardIndependentAudit (Chair), Compensation—Paid as an executive

The board of the latest proxy (FY2025).

Activity

Filings6

See all
Proxy statementDEF 14AApr 17, 2026FY2025
Annual report10-KMar 2, 2026FY2025
Proxy statementDEF 14AApr 18, 2025FY2024
Annual report10-KMar 27, 2025FY2024
Proxy statementDEF 14AApr 18, 2024FY2023
Annual report10-KMar 19, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data